The pro-oncogenic role of MAPK6 described here is also strongly supported by the observation that elevated MAPK6 mRNA expression negatively correlates with pan-cancer patient survival and survival in specific cancer types, including LUAD, MESO, UVM, and breast cancer. The gene discussed is MAPK6; the disease is breast carcinoma.